J, E., T, T., & J, P. (2016). Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: Role of nilotinib. Dove Medical Press.
Cita Chicago Style (17a ed.)J, Emole, Talabi T, y Pinilla-Ibarz J. Update on the Management of Philadelphia Chromosome Positive Chronic Myelogenous Leukemia: Role of Nilotinib. Dove Medical Press, 2016.
Cita MLA (8a ed.)J, Emole, et al. Update on the Management of Philadelphia Chromosome Positive Chronic Myelogenous Leukemia: Role of Nilotinib. Dove Medical Press, 2016.
Precaución: Estas citas no son 100% exactas.